Treatment-resistant schizophrenia: clinical experience with new antipsychotics

Author： Dufour H.   Bondolfi G.   Baumann P.   Seywert F.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 202-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aripiprazole Augmentation of Clozapine in Treatment-Resistant Schizophrenia: A Clinical Observation

By Ziegenbein Marc  

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 117-124

Adis International

Access to resources Recommend Favorite

Ziprasidone effective in treatment-resistant schizophrenia

By  

Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Despite safety concerns, clozapine has a unique profile of clinical benefits in patients with treatment-resistant schizophrenia or schizophrenia-associated suicidality

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 9-13

Adis International

Access to resources Recommend Favorite

Role of Newer Atypical Antipsychotics in the Management of Treatment- Resistant Schizophrenia

By Emsley R.A.  

CNS Drugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 409-420

Adis International

Access to resources Recommend Favorite

Adjunctive Depot Antipsychotic in Treatment-Resistant Schizophrenia

By  

Current Psychopharmacology, Vol. 5, Iss. 1, 2016-06 ,pp. : 20-27

Bentham Science Publishers

Access to resources Recommend Favorite